|
 |
 |
THE FUTURE OF RADIOLOGY |
|
 |
| Program work with molecular probes is leading to the next revolution in radiology: personalized cancer treatment. |
 |
|
|
Program researchers are exploiting the molecular signatures of different cancers to develop probes that can target specific intracellular and cell-surface molecules and report back on their activity. To collect a variety of data for visualization, researchers are developing multimodal strategies that combine optical, magnetic and radioactive reporter processes.
In addition to expanding our current understanding of cancer biology, these targeted probes may someday allow doctors to discover the disease in patients much earlier using only a few suspect cells rather than the billions needed by current methods, and to predict how patients will respond to different therapies. The probes are also being studied as potential vehicles for delivering therapeutic medications to malignant cells.
Visit the Molecular Imaging Program at Stanford (MIPS) website for more information about multimodality imaging strategies (http://mips.stanford.edu).
Scientific Goals
- Development of new reporter strategies for interrogating cancer biology in living subjects
- Development of novel multimodality molecular imaging probes for studying specific cellular/molecular events in living subjects
- Development of new methods to visualize anatomical and molecular imaging data
- Development of multimodality strategies for imaging cancer
Program Researchers
Francis Blankenberg, MD
Matthew Bogyo, PhD
Shawn Chen, PhD
Christopher Contag, PhD
Hongjie Dai, PhD
Sanjiv Gambhir, MD, PhD
|
Michael Goris, MD, PhD
Michael E. Moseley, PhD
Andrew Quon, MD
Jianghong Rao, PhD
Shan Wang, PhD
Paul Wender, PhD
|
|
